RKDA$0.1522-2.44%
Arcadia Biosciences, Inc.
Sector: Crude Petroleum & Natural GasIndustry: Agricultural InputsCountry: USExchange: Nasdaq
Mkt Cap:$366.7K
Float & O/S:
Inst Own:
DilutionScan read 29 of Arcadia Biosciences, Inc.'s SEC filings and found 20 warrant series, 2 shelf registrations and 2 completed offerings on file for RKDA. The latest dilution event on file is a registration statement on Jul 8, 2026. Analysis updated Oct 31, 2026.
Signal8 Summary
RKDA
Going-concern warning, delisting risk
Snapshot
Arcadia is a tiny consumer-products micro-cap (Zola coconut water) burning cash while its stock sits near its 52-week low. FY 2025 revenue was $4.9M, down 3.7%, with a $2.3M net loss.
What's Happening Right Now
- : Shareholders approved on September 10, 2026 a charter amendment letting the board carry out a 1-for-2 to 1-for-10 reverse stock split anytime before June 30, 2027 to address the sub-$1 share price.
- : Nasdaq notified Arcadia on August 31, 2026 that its stockholders' equity of $633,000 is below the $2.5 million minimum for continued listing, giving the company until October 15, 2026 to submit a compliance plan.
- : Arcadia's 10-Q for the quarter ended June 30, 2026 included going-concern language, warning its $4.2 million cash won't cover the next 12 months and it may need to cut spending, sell assets, or pursue bankruptcy without new funding.
- : Q2 2026 revenue was $1.443 million (down 1% YoY) with a $6.3 million net loss driven mostly by non-cash valuation charges; cash burn from operations was just $319,000 and the company highlighted rising Zola coconut water sales.
- : A September 2026 proxy asked holders to approve up to 3,993,296 new shares tied to Series A-1 options from a June 2026 private placement, a potential increase of roughly 161% versus the ~2.4 million shares then outstanding.
